3

FORM 3 SUBMISSION

Company: Lineage Cell Therapeutics, Inc.
Filed: May 23, 2013
Period of Report: May 13, 2013
Accession Number: 0001209191-13-028647

View Document ↗ View on SEC.gov ↗